NA
MDT icon

Navellier & Associates’s Medtronic MDT Stock Holding History

Navellier & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-191
Closed -$17K – 301
2016
Q2 		$17K Sell
191
-52
-21% -$4.21K ﹤0.01% 241
2016
Q1 		$18K Sell
243
-7
-3% -$527 ﹤0.01% 211
2015
Q4 		$19K Sell
250
-9,449
-97% -$711K ﹤0.01% 215
2015
Q3 		$649K Sell
9,699
-5,283
-35% -$389K 0.07% 121
2015
Q2 		$1.11M Buy
14,982
+3,334
+29% +$255K 0.1% 110
2015
Q1 		$908K Buy
+11,648
New +$883K 0.08% 124

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Navellier & Associates's MDT Position: Q3 2016 in Review

Navellier & Associates sold out of Medtronic (MDT) in Q3 2016, closing a stake of 191 shares — an estimated $17K sold.

Navellier & Associates first reported a position in MDT in Q1 2015 and held it in 6 quarters. The position peaked at $1.11M in Q2 2015. 1,266 funds tracked by Wall St. Rank hold MDT as of Q3 2016.

  • Navellier & Associates reported no remaining Medtronic position as of Q3 2016 after selling out during the quarter.
  • Navellier & Associates sold 191 Medtronic shares in Q3 2016, an estimated $17K.
  • Navellier & Associates first reported a position in Medtronic in Q1 2015 and held it in 6 quarters.
  • Navellier & Associates's Medtronic position peaked at $1.11M in Q2 2015.
  • 1,266 funds tracked by Wall St. Rank held Medtronic as of Q3 2016.

Based on Navellier & Associates's 13F filing for Q3 2016, filed 24 Oct 2016.